These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38775250)

  • 21. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
    Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; Pinto A; Berardi R; Zgura A; Mammone G; Ansari J; Atzori F; Chiari R; Bamias A; Caffo O; Procopio G; Sunela K; Bassanelli M; Ortega C; Grillone F; Landmesser J; Milella M; Messina C; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Morelli F; Incorvaia L; Rebuzzi SE; Roviello G; Soares A; Bisonni R; Bimbatti D; Zabalza IO; Rizzo A; Mollica V; Sorgentoni G; Monteiro FSM; Battelli N; Bracarda S; Porta C
    Eur Urol Oncol; 2024 Feb; 7(1):102-111. PubMed ID: 37481365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
    Panzuto F; Merola E; Rinzivillo M; Partelli S; Campana D; Iannicelli E; Pilozzi E; Mercantini P; Rossi M; Capurso G; Scarpa A; Cascinu S; Tomassetti P; Falconi M; Delle Fave G
    Pancreas; 2014 Mar; 43(2):212-8. PubMed ID: 24518498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
    Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
    Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
    Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients.
    Bozzetti F; Santarpia L; Pironi L; Thul P; Klek S; Gavazzi C; Tinivella M; Joly F; Jonkers C; Baxter J; Gramlich L; Chicharro L; Staun M; Van Gossum A; Lo Vullo S; Mariani L
    Ann Oncol; 2014 Feb; 25(2):487-93. PubMed ID: 24406425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
    Galli G; De Toma A; Pagani F; Randon G; Trevisan B; Prelaj A; Ferrara R; Proto C; Signorelli D; Ganzinelli M; Zilembo N; de Braud F; Garassino MC; Lo Russo G
    Lung Cancer; 2019 Nov; 137():38-42. PubMed ID: 31526910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors.
    Murata D; Azuma K; Matsuo N; Murotani K; Matama G; Kawahara A; Sasada T; Tokito T; Hoshino T
    Cancer Med; 2023 Oct; 12(19):19471-19479. PubMed ID: 37712645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 29. The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
    Oncology; 2023; 101(4):213-223. PubMed ID: 36626879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study.
    Morimoto K; Uchino J; Yokoi T; Kijima T; Goto Y; Nakao A; Hibino M; Takeda T; Yamaguchi H; Takumi C; Takeshita M; Chihara Y; Yamada T; Hiranuma O; Morimoto Y; Iwasaku M; Kaneko Y; Yamada T; Takayama K
    Oncoimmunology; 2021; 10(1):1950411. PubMed ID: 34290909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cachexia on outcomes in aggressive lymphomas.
    Karmali R; Alrifai T; Fughhi IAM; Ng R; Chukkapalli V; Shah P; Basu S; Nathan S; Szymanski-Grant K; Gordon LI; Venugopal P; Penedo FJ; Borgia JA
    Ann Hematol; 2017 Jun; 96(6):951-956. PubMed ID: 28417157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cachexia staging score predicts survival in patients with cancer who receive palliative care.
    Ueshima J; Maeda K; Shimizu A; Nagano A; Ishida Y; Takeuchi T; Nonogaki T; Matsuyama R; Yamanaka Y; Murotani K; Mori N
    Nutrition; 2023 Feb; 106():111880. PubMed ID: 36436335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study.
    de Clercq NC; van den Ende T; Prodan A; Hemke R; Davids M; Pedersen HK; Nielsen HB; Groen AK; de Vos WM; van Laarhoven HWM; Nieuwdorp M
    Clin Cancer Res; 2021 Jul; 27(13):3784-3792. PubMed ID: 33883174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab.
    Yamamoto S; Fukushima H; Fukuda S; Uehara S; Yasuda Y; Tanaka H; Yoshida S; Yokoyama M; Matsuoka Y; Fujii Y
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):410-418. PubMed ID: 34811871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
    Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy.
    Araki T; Kitaguchi Y; Suzuki Y; Komatsu M; Sonehara K; Wada Y; Tateishi K; Hanaoka M
    Thorac Cancer; 2021 Nov; 12(21):2857-2864. PubMed ID: 34599854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer.
    Fujii H; Makiyama A; Iihara H; Okumura N; Yamamoto S; Imai T; Arakawa S; Kobayashi R; Tanaka Y; Yoshida K; Suzuki A
    Anticancer Res; 2020 Dec; 40(12):7067-7075. PubMed ID: 33288604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.